US Stock MarketDetailed Quotes
GLYC GlycoMimetics
- 0.2420
- +0.0255+11.78%
Close Dec 24 13:00 ET
15.61MMarket Cap-0.39P/E (TTM)
0.2424High0.2050Low406.71KVolume0.2050Open0.2165Pre Close93.34KTurnover0.95%Turnover RatioLossP/E (Static)64.48MShares3.529952wk High1.38P/B10.36MFloat Cap0.140652wk Low--Dividend TTM42.82MShs Float26.0500Historical High--Div YieldTTM17.28%Amplitude0.1406Historical Low0.2290Avg Price1Lot Size
About GlycoMimetics Company
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Company Profile
SymbolGLYC
Company NameGlycoMimetics
Listing DateJan 10, 2014
Issue Price8.00
Founded2003
CEOMr. Harout Semerjian
MarketNASDAQ
Employees35
Fiscal Year Ends12-31
Address9708 Medical Center Drive
CityRockville
ProvinceMaryland
CountryUnited States of America
Zip Code20850
Phone1-240-243-1201
Websitehttp://www.glycomimetics.com
Company Executives
- Name
- Position
- Salary
- Harout Semerjian
- Director, President and Chief Executive Officer
- 2.39M
- Bruce S. Johnson
- Chief Commercial Officer and Senior Vice President
- --
- Chinmaya Rath
- Chief Business Officer and Senior Vice President
- --
- Brian M. Hahn
- Principal Accounting Officer, Chief Financial Officer and Senior Vice President
- 1.30M
- Timothy R. Pearson
- Chairman of the Board
- 138.00K
- Rachel K. King
- Director
- 96.00K
- Daniel M. Junius
- Independent Director
- 118.50K
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 111.00K
- Dr. Scott Koenig, M.D.,PhD
- Independent Director
- 100.50K
- Patricia S. Andrews
- Independent Director
- 105.00K
- Scott T. Jackson, M.B.A.
- Independent Director
- 111.00K
Heat List
US
Overall
Symbol
Price
% Chg
No Data
